The following changes to and additional risk statements will be required (with new verbiage in bold):
- “If you have a liver disorder, consult a healthcare practitioner prior to use. Stop use if you develop symptoms of liver trouble such as yellowing of the skin/eyes (jaundice), stomach pain, dark urine, sweating, nausea, unusual tiredness and/or loss of appetite and consult a healthcare practitioner”
- “Rare, unpredictable cases of liver injury associated with green tea extract-containing products have been reported (in Canada and internationally)”
Products that contain Green Tea Extract as a non-medicinal ingredient are required to report the amount of EGCG in the green tea and required to add the above stated risk statements.
As Health Canada must be notified stating companies containing GTE either as medicinal or non-medicinal ingredient the dates are as follows:
GTE as a non-medicinal ingredient and quantity of EGCG – December 14, 2017
GTE as a medicinal ingredient attestation – November 14, 2018
If you have a NPN licensed product containing Green Tea extract either as a medicinal ingredient or non-medicinal ingredient please contact Quality Smart Solutions today to assist you in notifying Health Canada about this important label update.
How We Can Help
At Quality Smart Solutions, we provide you with the guidance to plan your Veterinary Health Products business, navigate the legal requirements, and acquire the appropriate license for your operations.
Quality Smart Solutions has a team of professionals to offer support from day one of starting your business, including formulation and label reviews, Veterinary Health Product notifications and more.